Inventor
John Robert Springer
Inventor
Wentzville, MO, US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes20%
PatentTitleYear
10,815,213Bruton's tyrosine kinase inhibitors202010,316,038Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer201910,266,513Bruton's tyrosine kinase inhibitors201910,150,783Heterocyclic ITK inhibitors for treating inflammation and cancer20189,695,200'Heterocyclic ITK inhibitors for treating inflammation and cancer'20179,505,765'4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment'20169,499,551'Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases'20167,259,266'Benzopyran compounds useful for treating inflammatory conditions'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007Patents assigned to PHARMACIA CORP (1)· patent assignee history
2007Based in O'Fallon, MO, US· patent location history
2016–2017Patents assigned to CONFLUENCE LIFE SCIENCES INC (3)· patent assignee history
2016–2020Based in Wentzville, MO, US· patent location history
2018–2019Patents assigned to ACLARIS THERAPEUTICS INC (2)· patent assignee history
2019–2020Patents assigned to PFIZER (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CONFLUENCE LIFE SCIENCES INC | 3 | 2016–2017 |
| ACLARIS THERAPEUTICS INC | 2 | 2018–2019 |
| PFIZER | 2 | 2019–2020 |
| PHARMACIA CORP | 1 | 2007 |
Locations
| Location | Patents | Span |
|---|---|---|
| Wentzville, MO, US | 7 | 2016–2020 |
| O'Fallon, MO, US | 1 | 2007 |